German Co. Seeks Attys' Fees In $20M Cialis IP Trial
A German pharmaceutical company told a Texas federal court Thursday that Eli Lilly and Co. pursued frivolous arguments in a patent trial over new uses for the erectile dysfunction drug Cialis,...To view the full article, register now.
Already a subscriber? Click here to view full article